Gelteq

Global biotech company specialising in ingestible gel technologies for humans and animals, covering the pharmaceutical, healthcare, nutrition & sport sectors.

[Gelteq @gelteq]

Gelteq's future is bright with a focus across the world with a range of products and targets for 2025. Hear more directly from Co-Founder and Executive Chairman Simon Szewach in this video:

$GELS #Getleq #GelTechnology

[Gelteq @gelteq]

#ICYMI, Gelteq launched earlier this week the SportsGel (https://t.co/M0tu5r8wzx) brand along with the brand's first distribution partner WPIC Marketing + Technologies. Read more from Drug Development & Delivery:

https://t.co/RU7VcSvU1V

$GELS #Gelteq

[Gelteq @gelteq]

Gelteq announced this morning the launch of its SportsGel brand along with its first distribution agreement with WPIC Marketing + Technologies. Read more in our latest press release here:

https://t.co/3JAOzDImsX

$GELS #Gelteq #Sports

[Gelteq @gelteq]

CEO Nathan Givoni was interviewed for two thought leadership pieces for @pharmasalmanac discussing personalized medicine and sustainability. Check them out below:

https://t.co/gnfFRcC7gy

https://t.co/rLST9VMJdX

#Gelteq $GELS #Leadership

[Gelteq @gelteq]

Gelteq's formulation has enormous potential for drug delivery in the place of traditional pills, powders and tablets. Listen to Gelteq Co-Founder and Executive Chairman Simon Szewach talk about the benefits the gel formulation can have:

$GELS #Gelteq #GelTechnology

[Gelteq @gelteq]

Gelteq announced this morning the appointment of Matthew Jones as Head of Sports Performance. Jones is a leading internationally-experienced sports dietitian with more than 12 years of applied experience in elite sports.

https://t.co/8sOLNc4PjY

$GELS #Gelteq

[Gelteq @gelteq]

What is Gelteq?

Hear directly from Co-Founder and CEO Nathan Givoni about the technology Gelteq has developed to help those who may have trouble swallowing traditional pills and tablets:

$GELS #Gelteq #GelFormulation

[Gelteq @gelteq]

#ICYMI, Gelteq announced a 50% increase in purchase orders from its largest U.S. customer, @HealthyExtracts. Read more about Gelteq, it's business and the path forward in this article from BioPharma Journal:

https://t.co/FB3GIcw43N

$GELS #Gelteq

[Gelteq @gelteq]

Gelteq Co-Founder and Executive Chairman Simon Szewach recently joined @BizOfPharmPod to discuss the business journey behind our gel platform technology and how it can change drug delivery. Take a listen here:

https://t.co/cjCMw9YRqH

$GELS #Gelteq #GelTechnology

[Gelteq @gelteq]

CEO Nathan Givoni recently joined Drug Delivery Leader for their Sit and Deliver Podcast to talk expanding accessibility in drug delivery platforms through a gel-based technology. Listen to the full interview:

https://t.co/yY2xoNKdi6

#Gelteq #Dysphagia #Accessibility $GELS

[Gelteq @gelteq]

Gelteq Co-Founders Nathan and Simon recently sat down with @_ASAI to talk about the company's customizable technology, catering to those with dysphagia, children, adults, seniors, and even animals. Learn more in the full Q&A linked here:

https://t.co/vV1qydSvGH

#Gelteq $GELS

[Gelteq @gelteq]

Gelteq's Executive Chairman Simon Szewach recently joined @tjernlund and the Nano Cap Podcast to discuss Gelteq's drug delivery system and listing. Listen to the full podcast here or wherever you get your podcasts:

https://t.co/Zipk0tgBkr

$GELS #Gelteq #GelTechnology

[Gelteq @gelteq]

Gelteq Co-Founders recently sat down with @_ASAI to discuss the company's business model and future. Gelteq's customizable tech can cater to those with dysphagia, children, adults, seniors, and even animals. Learn more: 

https://t.co/vV1qydSvGH

#Gelteq $GELS #GelTechnology

[Gelteq @gelteq]

Gelteq announced today the appointment of Dr. Paul Wynne as its Chief Scientific Officer. Dr. Wynne will oversee the product and formulation strategies and the growth of Gelteq’s scientific team and various business verticals. Read more: https://t.co/aSWvUpNwDQ

#Gelteq $GELS

[Gelteq @gelteq]

Gelteq has announced today that the FDA has approved its suitability petition for a new animal drug under development. Approval grants Gelteq fast track pathway for drug and entrance into the animal pharmaceuticals space. Read more: https://t.co/EGfGYP9XAb

#Gelteq $GELS

[Gelteq @gelteq]

Our Co-Founders Nathan Givoni and Simon Szewach will be participating in the @benchmark Company 13th Annual Discovery Investor Conference on December 11th in NYC.

Learn more in our press release: https://t.co/5OW8nhJync

#Gelteq $GELS #GelPlatform

[Gelteq @gelteq]

Gelteq announces its largest U.S. customer, @HealthyExtracts has increased its initial purchase order of Gelteq collagen and Mynus sugar blocker gels by 50%, citing the high demand and popularity. Read more:

https://t.co/Ewavt5WsRQ

#Gelteq $GELS #HealthyExtracts #GelPlatform

[Gelteq @gelteq]

Happy Thanksgiving! Wishing a joyful Thanksgiving holiday to our clients, friends, and staff in the United States today.

$GELS #Gelteq #GelFormulations #GelTechnology #Thanksgiving

[Gelteq @gelteq]

Gelteq announced today 400,000 units entered into production in November 2024. The production includes Gelteq nutraceutical products in the areas of sports, anti-aging, and weight loss. Read more in our latest press release: https://t.co/T8p7AP33IM

$GELS #Gelteq #GelTechnology

[Gelteq @gelteq]

Gelteq announced this week the appointment of Adam Bendell as President of U.S. Operations to scale domestic business and operations. Read more in our latest press release:

https://t.co/oh2cyM4Ob2

$GELS #Gelteq #GelTechnology